BridgeBio Pharma (BBIO) Restructuring Costs (2022 - 2025)
BridgeBio Pharma recorded quarterly Restructuring Costs of $11.1 million in Q4 2025, up 25.9% quarter-over-quarter from $8.8 million in Q3 2025, and up 137.18% year-over-year from $4.7 million in Q4 2024.
BridgeBio Pharma's Restructuring Costs history runs 4 years deep, the most recent figure standing at $11.1 million for Q4 2025.
- In Q4 2025, Restructuring Costs rose 137.18% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $20.7 million (up 69.03% YoY), while the FY2025 annual figure was $21.3 million, up 36.8% from the prior year.
- Restructuring Costs came in at $11.1 million for Q4 2025 at BridgeBio Pharma, up from $8.8 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $22.7 million in Q1 2022 to a low of $272000.0 in Q3 2023.
- A 4-year average of $5.4 million and a median of $4.1 million in 2023 frame the typical range for Restructuring Costs.
- Across the five-year window, Restructuring Costs slumped 94.58% in 2023 and surged 1598.9% in 2024, its largest moves.
- BridgeBio Pharma's Restructuring Costs stood at $7.7 million in 2022, then tumbled by 90.2% to $754000.0 in 2023, then surged by 522.41% to $4.7 million in 2024, then soared by 137.18% to $11.1 million in 2025.
- According to Business Quant data, Restructuring Costs over the past three periods registered $11.1 million, $8.8 million, and $712000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.13 Mn |
| Sep 30, 2025 | 8.84 Mn |
| Jun 30, 2025 | 712,000.00 |
| Mar 31, 2025 | 570,000.00 |
| Dec 31, 2024 | 4.69 Mn |
| Sep 30, 2024 | 4.62 Mn |
| Jun 30, 2024 | 2.35 Mn |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 754,000.00 |
| Sep 30, 2023 | 272,000.00 |
| Jun 30, 2023 | 3.53 Mn |
| Mar 31, 2023 | 3.37 Mn |
| Dec 31, 2022 | 7.69 Mn |
| Sep 30, 2022 | 5.02 Mn |
| Jun 30, 2022 | 8.40 Mn |
| Mar 31, 2022 | 22.66 Mn |